B
BIO
BIOVerified2 segments tracked|8 years of data|Annual (10-K)
Total Revenue
$2.6B0.7%
FY2025
Operating Segments
2Active segments
Blended Margin
0.0%Operating margin
Highest Margin
0.0%Clinical Diagnostics
Segment Shift
Clinical Diagnostics has grown from 62.1% to 60.5% of total revenue since FY2018, with 0.0% operating margins.
Segment Revenue Over Time
Revenue Mix
Segment Breakdown — FY2025
| Segment | Revenue | Op. Income | Margin | % of Total | YoY |
|---|---|---|---|---|---|
| Clinical Diagnostics | $1.6B | $0 | 0.0% | 60.5% | +1.6% |
| Life Science | $1.0B | $0 | 0.0% | 39.5% | -0.7% |
Want more? Unlock the full analysis.
Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.
Get Started Free